Pharmaceutical News

RSS

Columbia University professor recommends vaccination for people travelling abroad

Planning to travel outside the U.S. this holiday season? Check with your primary care provider or travel clinic when you book your flight.

16 Oct 2014

Federal prescription-subsidy program improves drug adherence in breast cancer patients

A federal prescription-subsidy program for low-income women on Medicare significantly improved their adherence to hormone therapy to prevent the recurrence of breast cancer after surgery.

16 Oct 2014

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.

15 Oct 2014

Scientists create light-activated drug to help control type 2 diabetes

Scientists have created a drug for type 2 diabetes that is switched on by blue light, which they hope will improve treatment of the disease.

15 Oct 2014

Discovery could prolong life of people living with glioblastoma

Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.

14 Oct 2014

I.V. lidocaine can protect mastectomy patients against chronic pain

More than two-thirds of women who have had mastectomies struggle with persistent pain, but it doesn't have to be that way.

14 Oct 2014

Eye Co receives patent for new class of eye disease drugs

Australian ocular technology company Eye Co Pty Ltd has achieved a key commercial milestone, with a patent granted protecting its new class of eye disease drugs throughout the high value European market.

14 Oct 2014

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Helsinn Group and Eisai Inc. announced today that the Food and Drug Administration (FDA) approved AKYNZEO® for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.

13 Oct 2014

Pharmaceutical industry withdraws from the antibiotic space

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive.

13 Oct 2014

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Cough is among the most common complaints for which patients seek medical attention. Leading cough researcher Peter V. Dicpinigaitis, M.D., Professor of Clinical Medicine at New York's Albert Einstein College of Medicine, recently conducted a new cough challenge study among adults, whose results were first presented at the European Respiratory Society International Congress in September 2014.

13 Oct 2014

Pneumococcal vaccine prevents illness, reduces severe antibiotic-resistant infections in young children

The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being presented at IDWeek 2014.

12 Oct 2014

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Cumberland Pharmaceuticals Inc. today announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, Louisiana.

12 Oct 2014

Slug flow microextraction method for drug testing yields results in one minute

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

10 Oct 2014

Vancomycin drug still effective in treating Staphylococcus aureus bloodstream infections

A University of Nebraska Medical Center research team has determined that a longtime antibiotic, vancomycin, is still effective in treating Staphylococcus aureus bloodstream infections and that physicians should continue to use the drug even though several newer antibiotics are now available in the marketplace.

10 Oct 2014

Researchers compare effects of early and late epidurals given during labour

When a woman is in labour, the appropriate time to give an epidural during childbirth is when she asks for it, a new study suggests.

9 Oct 2014

Researchers develop nanoparticle eye drops to combat dry eye syndrome

For the millions of sufferers of dry eye syndrome, their only recourse to easing the painful condition is to use drug-laced eye drops three times a day.

9 Oct 2014

New Colombia creates joint venture to produce cannabis and hemp based medicinal products

New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce they have formed a joint venture to produce cannabis and hemp based medicinal products in Colombia in association with an indigenous community in Colombia.

9 Oct 2014

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014.

9 Oct 2014

Pharmaceutical News

Columbia University professor recommends vaccination for people travelling abroad

Federal prescription-subsidy program improves drug adherence in breast cancer patients

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Scientists create light-activated drug to help control type 2 diabetes

Discovery could prolong life of people living with glioblastoma

I.V. lidocaine can protect mastectomy patients against chronic pain

Eye Co receives patent for new class of eye disease drugs

Eisai, Helsinn Group announce FDA approval of AKYNZEO for prevention of CINV

Pharmaceutical industry withdraws from the antibiotic space

Study shows diphenhydramine suppresses cough reflex sensitivity with Dr. Cocoa formulation

Pneumococcal vaccine prevents illness, reduces severe antibiotic-resistant infections in young children

Preoperative IV ibuprofen improves quality of recovery after laparoscopic cholecystectomy surgery

Slug flow microextraction method for drug testing yields results in one minute

Vancomycin drug still effective in treating Staphylococcus aureus bloodstream infections

Researchers compare effects of early and late epidurals given during labour

Researchers develop nanoparticle eye drops to combat dry eye syndrome

New Colombia creates joint venture to produce cannabis and hemp based medicinal products

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News